Clinical Trial Update: A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review

View source ↗

Summary

A completed observational study in Chinese participants with atopic dermatitis evaluating how patients are treated with upadacitinib, including clinical outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (Rinvoq) (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis (AD) | Status: COMPLETED